PKU patients may have hidden inflammation, study suggests

NCT ID NCT04879277

Completed Knowledge-focused Sponsor: University Hospital, Tours Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 40 adults—some with phenylketonuria (PKU) and some healthy—to see if PKU causes low-level inflammation in the body. Researchers measured inflammatory markers in blood samples. The goal was to better understand how PKU affects overall health, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help understand how phenylketonuria affects the body beyond the brain, possibly pointing to new ways to manage the condition.
What could go wrong: This is a small, completed observational study with only 40 participants. It measures markers of inflammation, not a treatment, so it may not lead directly to any new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

phenylketonuria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PHENYLKETONURIA

Contacts and locations

Locations

Clinical investigation center, University Hospital, Tours

Tours, 37044, France
Internal Medicine Service, University Hospital, Tours

Tours, 37044, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.